FDA Global Summit on Regulatory Science

The US Food and Drug Administration hosted on September 7 - 9, 2016, a regulatory science summit focused on nanotechnology standards and applications. Proceedings from the summit will be available soon.

 

Nanomedicines: From Bench to Bedside and Beyond

The Nanomedicines Alliance's white paper "Nanomedicines:  From Bench to Bedside and Beyond" has been accepted for publication in the November 2016 issue of the AAPS Journal.

​

The Nanomedicines Alliance on Capitol Hill

The Nanomedicines Alliance Advocacy Working Group, in partnership with the District Policy Group at Drinker, Biddle & Reath, LLP, held a series of meetings at Congress on March 22 to educate policymakers on nanomedicine. In ten meetings with congressional members and staff, our members explained the potential of nanotechnology, highlighted recent successes in the field, and stressed the need for continuous support of advancing research to commercialization.

 

If you are interested in more information on our advocacy efforts and on public education in nanotechnology, contact the Nanomedicines Alliance at info@nanomedicines-alliance.org.

 

AAPS Nanomedicines Themed Issue

Dr. Marc Wolfgang, Vice Chair of the Nanomedicines Alliance, is co-editing a themed issue for the AAPS Journal on Nanomedicines with Dr. Katherine Tyner of the Food and Drug Administration. Look for publication soon.

​

Leading Nanotechnology Scientist Receives National Medal of Technology and Innovation

Dr. Joseph DeSimone, a leading scientist and founder in the nanomedicine space, has been awarded the National Medal of Science and National Medal of Technology and Innovation by the White House for 2016. Dr. DeSimone is the founder of Liquidia Technologies and a professor at the University of North Carolina at Chapel Hill.